BC
ATRS
Broadfin Capital’s Antares Pharma, Inc. ATRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-1,336,700
| Closed | -$4.47M | – | 48 |
|
2019
Q3 | $4.47M | Sell |
1,336,700
-407,447
| -23% | -$1.36M | 0.83% | 28 |
|
2019
Q2 | $5.74M | Sell |
1,744,147
-899,800
| -34% | -$2.96M | 1.25% | 24 |
|
2019
Q1 | $8.01M | Sell |
2,643,947
-800,200
| -23% | -$2.42M | 1.65% | 23 |
|
2018
Q4 | $9.37M | Sell |
3,444,147
-1,179,100
| -26% | -$3.21M | 1.23% | 20 |
|
2018
Q3 | $15.5M | Hold |
4,623,247
| – | – | 2.29% | 12 |
|
2018
Q2 | $11.9M | Sell |
4,623,247
-50,000
| -1% | -$129K | 1.88% | 19 |
|
2018
Q1 | $10.3M | Buy |
4,673,247
+137,600
| +3% | +$303K | 1.6% | 21 |
|
2017
Q4 | $9.03M | Buy |
4,535,647
+1,329,747
| +41% | +$2.65M | 1.48% | 21 |
|
2017
Q3 | $10.4M | Sell |
3,205,900
-1,597,628
| -33% | -$5.18M | 1.54% | 18 |
|
2017
Q2 | $15.5M | Sell |
4,803,528
-2,838,678
| -37% | -$9.14M | 1.88% | 16 |
|
2017
Q1 | $21.7M | Sell |
7,642,206
-5,328,887
| -41% | -$15.1M | 2.63% | 9 |
|
2016
Q4 | $30.2M | Sell |
12,971,093
-1,914,300
| -13% | -$4.46M | 3.36% | 6 |
|
2016
Q3 | $25M | Hold |
14,885,393
| – | – | 2.24% | 11 |
|
2016
Q2 | $15.6M | Sell |
14,885,393
-200,000
| -1% | -$210K | 1.52% | 18 |
|
2016
Q1 | $13.1M | Buy |
15,085,393
+3,610,393
| +31% | +$3.14M | 1.27% | 20 |
|
2015
Q4 | $13.9M | Buy |
11,475,000
+3,000,000
| +35% | +$3.63M | 0.85% | 29 |
|
2015
Q3 | $14.4M | Buy |
8,475,000
+900,000
| +12% | +$1.53M | 0.8% | 29 |
|
2015
Q2 | $15.8M | Buy |
7,575,000
+2,875,000
| +61% | +$5.98M | 0.85% | 31 |
|
2015
Q1 | $12.7M | Hold |
4,700,000
| – | – | 0.99% | 25 |
|
2014
Q4 | $12.1M | Buy |
4,700,000
+1,000,000
| +27% | +$2.57M | 1.05% | 26 |
|
2014
Q3 | $6.77M | Buy |
3,700,000
+650,000
| +21% | +$1.19M | 0.71% | 41 |
|
2014
Q2 | $8.14M | Buy |
3,050,000
+750,000
| +33% | +$2M | 0.79% | 41 |
|
2014
Q1 | $8.05M | Buy |
2,300,000
+1,500,000
| +188% | +$5.25M | 0.78% | 41 |
|
2013
Q4 | $3.58M | Buy |
+800,000
| New | +$3.58M | 0.47% | 45 |
|